These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32928457)

  • 1. Outcomes of an Emergency Department Observation Unit-Based Pathway for the Treatment of Uncomplicated Vaso-occlusive Events in Sickle Cell Disease.
    Lyon M; Sturgis L; Lottenberg R; Gibson ME; Eck J; Kutlar A; Gibson RW
    Ann Emerg Med; 2020 Sep; 76(3S):S12-S20. PubMed ID: 32928457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
    Allen Liles E; Kirsch J; Gilchrist M; Adem M
    Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
    Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
    CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
    Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
    Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell disease.
    Karkoska K; Appiah-Kubi A; Rocker J; Stoffels G; Aygun B
    Br J Haematol; 2019 Sep; 186(6):855-860. PubMed ID: 31148158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
    Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
    J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency Department (ED), ED Observation, Day Hospital, and Hospital Admissions for Adults with Sickle Cell Disease.
    Cline DM; Silva S; Freiermuth CE; Thornton V; Tanabe P
    West J Emerg Med; 2018 Mar; 19(2):311-318. PubMed ID: 29560059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study.
    Lanzkron S; Little J; Wang H; Field JJ; Shows JR; Haywood C; Saheed M; Proudford M; Robertson D; Kincaid A; Burgess L; Green C; Seufert R; Brooks J; Piehet A; Griffin B; Arnold N; Frymark S; Wallace M; Abu Al Hamayel N; Huang CY; Segal JB; Varadhan R
    Ann Intern Med; 2021 Sep; 174(9):1207-1213. PubMed ID: 34224261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.
    Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM
    Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department.
    Schefft MR; Swaffar C; Newlin J; Noda C; Sisler I
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27274. PubMed ID: 29856534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic Health Record-Embedded Individualized Pain Plans for Emergency Department Treatment of Vaso-occlusive Episodes in Adults With Sickle Cell Disease: Protocol for a Preimplementation and Postimplementation Study.
    Luo L; King AA; Carroll Y; Baumann AA; Brambilla D; Carpenter CR; Colla J; Gibson RW; Gollan S; Hall G; Klesges L; Kutlar A; Lyon M; Melvin CL; Norell S; Mueller M; Potter MB; Richesson R; Richardson LD; Ryan G; Siewny L; Treadwell M; Zun L; Armstrong-Brown J; Cox L; Tanabe P
    JMIR Res Protoc; 2021 Apr; 10(4):e24818. PubMed ID: 33861209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell disease.
    Carullo V; Morrone K; Weiss M; Choi J; Gao Q; Pisharoty S; Moody K; Manwani D
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29665. PubMed ID: 35294090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
    Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
    Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain.
    Carden MA; Brousseau DC; Ahmad FA; Bennett J; Bhatt S; Bogie A; Brown K; Casper TC; Chapman LL; Chumpitazi CE; Cohen D; Dampier C; Ellison AM; Grasemann H; Hickey RW; Hsu LL; Leibovich S; Powell E; Richards R; Sarnaik S; Weiner DL; Morris CR;
    Am J Hematol; 2019 Jun; 94(6):689-696. PubMed ID: 30916794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Use of Individualized Pain Plans in Sickle Cell Patients Presenting to the Emergency Department.
    Della-Moretta S; Delatore L; Purcell M; Huang Y; Heinlein M; Adkins E; Desai P
    Ann Emerg Med; 2020 Sep; 76(3S):S21-S27. PubMed ID: 32928458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "The project did not come to us with a solution": Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease.
    Baumann AA; Hankins JS; Hsu LL; Gibson RW; Richardson LD; Treadwell M; Glassberg JA; Bourne S; Luo L; Masese RV; Demartino T; Nocek J; Taaffe E; Gollan S; Ruiz OO; Nwosu C; Qashou N; James AS; Tanabe P; King AA
    BMC Health Serv Res; 2023 Nov; 23(1):1245. PubMed ID: 37953236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
    Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
    Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of short-term emergency department observation care of children with sickle cell disease and vaso-occlusive crises: initial experience from south-western Nigeria.
    Adegoke SA; Oladimeji OI; Ologun BG; Aladekomo TA; Oyelami OA
    Trans R Soc Trop Med Hyg; 2020 May; 114(5):365-371. PubMed ID: 32181486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
    van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
    Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.